Jason R. Kelly

CIK: 0001845677

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (33.3%)

Position reduction

Option Exercises (M)4 (44.4%)

Derivative conversions

Awards (A)2 (22.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

DNA

Ginkgo Bioworks Holdings, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

DNA
Ginkgo Bioworks Holdings, Inc.
Oct 19, 2026
Sale(S)
Direct
45.7K shares at avg. $10.14$463K
DNA
Ginkgo Bioworks Holdings, Inc.
Oct 16, 2026
Exercise(M)
Direct
55.7K shares-
DNA
Ginkgo Bioworks Holdings, Inc.
Oct 16, 2026
Exercise(M)
Direct
25.8K shares-
DNA
Ginkgo Bioworks Holdings, Inc.
Jul 28, 2026
Award(A)
Restricted Stock Units
Direct
309.5K shares-
DNA
Ginkgo Bioworks Holdings, Inc.
Jul 28, 2026
Award(A)
Restricted Stock Units
Direct
74.3K shares-
DNA
Ginkgo Bioworks Holdings, Inc.
Apr 9, 2026
Sale(S)
Direct
109.8K shares at avg. $6.40$702K
DNA
Ginkgo Bioworks Holdings, Inc.
Apr 8, 2026
Sale(S)
Direct
97K shares at avg. $6.93$672K
DNA
Ginkgo Bioworks Holdings, Inc.
Apr 8, 2026
Exercise(M)
Direct
212.9K shares-
DNA
Ginkgo Bioworks Holdings, Inc.
Apr 7, 2026
Exercise(M)
Direct
212.9K shares-

		Type	Shares	Price		Ownership
Oct 19, 2026	DNA Ginkgo Bioworks Holdings, Inc.	Sale(S)	45,682	$10.14	$463,353	Direct
Oct 16, 2026	DNA Ginkgo Bioworks Holdings, Inc.	Exercise(M)	55,694	-	$0	Direct
Oct 16, 2026	DNA Ginkgo Bioworks Holdings, Inc.	Exercise(M)	25,790	-	$0	Direct
Jul 28, 2026	DNA Ginkgo Bioworks Holdings, Inc.	Award(A) Restricted Stock Units	309,467	-	-	Direct
Jul 28, 2026	DNA Ginkgo Bioworks Holdings, Inc.	Award(A) Restricted Stock Units	74,258	-	-	Direct
Apr 9, 2026	DNA Ginkgo Bioworks Holdings, Inc.	Sale(S)	109,767	$6.40	$702,179	Direct
Apr 8, 2026	DNA Ginkgo Bioworks Holdings, Inc.	Sale(S)	97,015	$6.93	$672,314	Direct
Apr 8, 2026	DNA Ginkgo Bioworks Holdings, Inc.	Exercise(M)	212,949	-	$0	Direct
Apr 7, 2026	DNA Ginkgo Bioworks Holdings, Inc.	Exercise(M)	212,949	-	$0	Direct

1-9 of 9 transactions

About Kelly Jason R

Kelly Jason R (SEC CIK 0001845677) files insider reports with the SEC as Director of Ginkgo Bioworks Holdings, Inc. (DNA).

Signal8 holds 3 ownership filings by Kelly Jason R, all Form 4s, filed between Apr 10, 2026 and Oct 21, 2026. Those filings report 9 transactions, from Apr 7, 2026 to Oct 19, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kelly Jason R's filings is in BOSTON, MA.

Recent filings by Kelly Jason R

Oct 19, 2026: Open-market sale of DNA shares (Form 4, code S).
Oct 16, 2026: Option exercises of DNA shares (2 lines, Form 4, code M).
Jul 28, 2026: Grants or awards of DNA derivative securities (2 lines, Form 4, code A).
Apr 9, 2026: Open-market sale of DNA shares (Form 4, code S).
Apr 8, 2026: Open-market sale of DNA shares (Form 4, code S).

Other insiders filing for Ginkgo Bioworks Holdings, Inc. (DNA)

How to read Form 4 transaction codes